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The study was undertaken to investigate the effect of FOY on the levels of 
plasma plasminogen (measured by chromogenic substrate S-2251) and high molecular 
weight (HMW) kininogen (measured by the bioassay using the rat uterus) during 
extracorporeal circulation with use of heart-lung machine, as compared with the 
control untreated with FOY. 
FOY l,OOOmg (10 vials) was dissolved in 500ml of glucose solution and infused 
at the rate of 400mg/200ml/60minutes into the reservoir installed in the circuit of 
the heart lung machine. Blood samples were collected from the radial artery before 
and after extracorporeal circulation and from the arterial line of the extracorporeal 
circuit during extracorporeal circulation. 
The basic therapy such as heparin (3 mg/kg) and aprotinin (50,000-100,000U/ 
person), which had been employed before the present trial, was continued without 
change. 
The results are shown in the attached tables and figures. As compared with the 
values before initiating extracorporeal circulation, the both of plasminogen and 
HMW kininogen levels were remarkably reduced in the control group, whereas no 
significant change was observed in the FOY-treated group. FOY significantly inhibit-
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e.c.c. : extracorporeal circulation 
Table. 5 FOY-treated group in which HMW 
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FOY -treated group in which 
plasminogen was measured 
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FOY -treated group 
mean土sd(n) 
21.2±21.0 (10) 
Table. 6 Plasminogen measured gro叫P
p 
Age I 







80.3土35.4(I) ! ns 






During , 80.50±13.83幅掛 73.70土14.66(4() i p<0.05 
e.c.c. 1 日7.05土17.22%] [86.13土17.67%] : [p<O.Ol] 
Post- : 85.仇 4剖（4) 1回∞土19・01(7) i ns 
e.c.c. i 四6.25土忌73%] ' [95尉土18.72%] i [ns] 
[ ] :Par官nthesizedfigures are % of pre e.c.c. values. 













































Po唱t- 4.14土1.11(7) 3.18土2.51(4) I ns 
e.c心［89.29土27.29%] [68.5土21.67%] I [ns〕
［〕： Parenthesizedfigures are % of pre-e.c.c. values. 































Fig. 1 Plasminogen levels before, during and after extracorporeal 
circulatoin 
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Fig. 2 HMW kininogen levels before, during and after extracorporeal circulation 
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